{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:16:36Z","timestamp":1769879796028,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.domaniend.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T16:51:45Z","timestamp":1525884705000},"page":"80-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus"],"prefix":"10.1016","volume":"65","author":[{"given":"M.A.","family":"Scuderi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ribeiro Petito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Unniappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mehain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"McMillian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"Snead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2018.04.003_bib1","first-page":"433","article-title":"Prevalence of feline diabetes mellitus in a feline private practice","volume":"17","author":"Baral","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jfms.2007.02.004","article-title":"Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals","volume":"9","author":"Prahl","year":"2007","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2018.04.003_bib3","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-14-0202","article-title":"Animal models of disease: classification and etiology of diabetes in dogs and cats","volume":"222","author":"Nelson","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygcen.2012.11.019","article-title":"Diabetes from humans to cats","volume":"182","author":"Osto","year":"2013","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/193229681200600306","article-title":"The cat as a model for human obesity and diabetes","volume":"6","author":"Hoenig","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/030098588101800507","article-title":"Feline insular amyloid: association with diabetes mellitus","volume":"18","author":"Yano","year":"1981","journal-title":"Vet Pathol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1098612X15571880","article-title":"ISFM consensus guidelines on the practical management of diabetes mellitus in cats","volume":"17","author":"Sparkes","year":"2015","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jfms.2000.0057","article-title":"Current understanding of feline diabetes: part 2, treatment","volume":"2","author":"Martin","year":"2000","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cvsm.2012.11.004","article-title":"The role of diet in the prevention and management of feline diabetes","volume":"43","author":"Zoran","year":"2013","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.domaniend.2018.04.003_bib10","series-title":"Canine & feline Endocrinology","first-page":"289","article-title":"Feline diabetes mellitus","author":"Reusch","year":"2015"},{"key":"10.1016\/j.domaniend.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1152\/ajpregu.00313.2006","article-title":"Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss","volume":"292","author":"Hoenig","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib12","series-title":"Textbook of veterinary internal medicine-disease of the dog and cat","first-page":"1796","article-title":"Diabetes mellitus","author":"Nelson","year":"2010"},{"key":"10.1016\/j.domaniend.2018.04.003_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1098612X12446211","article-title":"Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control","volume":"14","author":"Roomp","year":"2012","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/obr.12421","article-title":"The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond","volume":"17","author":"Jo\u00e3o","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.domaniend.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.domaniend.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1463-1326.2011.01444.x","article-title":"Incretin hormones and the expanding families of glucagon-like sequences and their receptors","volume":"13","author":"Irwin","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.domaniend.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.domaniend.2011.01.002","article-title":"The incretin effect in cats: comparison between oral glucose, lipids and amino acids","volume":"40","author":"Gilor","year":"2011","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.domaniend.2014.04.006","article-title":"Effects of sitagliptin on plasma incretin concentrations after glucose administration though an esophagostomy tube or feeding in healthy cats","volume":"49","author":"Nishii","year":"2014","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.domaniend.2011.03.001","article-title":"GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats","volume":"41","author":"Gilor","year":"2011","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsb\u00f8ll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00125-008-1195-5","article-title":"Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes","volume":"52","author":"H\u00f8jberg","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MED.0b013e32825ea2ba","article-title":"Incretins and their role in the management of diabetes","volume":"14","author":"Frias","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.domaniend.2018.04.003_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/dia.2009.0127","article-title":"The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes \u2013 a comprehensive review","volume":"12","author":"Garg","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.domaniend.2018.04.003_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.clinthera.2006.05.006","article-title":"Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus","volume":"28","author":"Iltz","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.domaniend.2018.04.003_bib25","first-page":"147","article-title":"Effects of a glucagon-like Peptide-1 mimetic (exenatide) in healthy cats","volume":"10","author":"Seyfert","year":"2012","journal-title":"Intern J Appl Res Vet Med"},{"key":"10.1016\/j.domaniend.2018.04.003_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.domaniend.2014.12.003","article-title":"Pharmacology of the glucagon-like pepetide-1 analog Exenatide extended-release in healthy cats","volume":"51","author":"Rudinsky","year":"2015","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.domaniend.2014.12.001","article-title":"Pharmacokinetics and pharmacodynamics of the glucagon-like pepetide-1 analog liraglutide in healthy cats","volume":"51","author":"Hall","year":"2015","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.rvsc.2014.12.001","article-title":"Effects of the glucagon-like peptide analogues exenatide, exenatide extended-release, and of the dipeptidylpeptidase-4 (DPP-4) inhibitor sitagliptin on glucose metabolism in healthy cats","volume":"99","author":"Padrutt","year":"2015","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.domaniend.2018.04.003_bib29","doi-asserted-by":"crossref","first-page":"e0154727","DOI":"10.1371\/journal.pone.0154727","article-title":"A placebo-controlled study on the effects of the glucagon-like peptide-1 mimetic, exenatide, on insulin secretion, body Composition and adipokines in obese, client-owned cats","volume":"11","author":"Hoelmkjaer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.domaniend.2018.04.003_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jvim.13817","article-title":"Effect of the glucagon-like peptide-1 analogue exenatide extended release in cats with newly diagnosed diabetes mellitus","volume":"30","author":"Reiderer","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2018.04.003_bib31","first-page":"13","article-title":"Development and validation of a body condition score system for cats: a clinical tool","volume":"25","author":"Laflamme","year":"1997","journal-title":"Feline Pract"},{"key":"10.1016\/j.domaniend.2018.04.003_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/jfms.2000.0103","article-title":"Plasma leptin concentrations in cats: reference range, effect of weight gain and relationship with adiposity as measured by dual energy X-ray absorptiometry","volume":"2","author":"Appleton","year":"2000","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2018.04.003_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1939-165x.2012.00476.x","article-title":"Validation of an enzymes-linked immunosorbent assay for measurement of feline serum insulin","volume":"41","author":"Strage","year":"2012","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-014-3283-z","article-title":"Hyperglucagonaemia analyzed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?","volume":"57","author":"Wewer Albrechtsen","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.domaniend.2018.04.003_bib35","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1292\/jvms.65.1207","article-title":"Feline leptin: immunogenic and biological activities of the recombinant protein, and its measurement by ELISA","volume":"65","author":"Shibata","year":"2003","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.domaniend.2018.04.003_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tvjl.2010.04.004","article-title":"Obesity, its associated disorders and the role of inflammatory adipokines in companion animals","volume":"185","author":"German","year":"2010","journal-title":"Vet J"},{"key":"10.1016\/j.domaniend.2018.04.003_bib37","doi-asserted-by":"crossref","first-page":"d7771","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"334","author":"Vilsb\u00f8ll","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.domaniend.2018.04.003_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/dc11-0931","article-title":"Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes","volume":"35","author":"Dushay","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.domaniend.2018.04.003_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6823-11-9","article-title":"Exenatide once wkly treatment maintained improvements in glycemic control and weight loss over 2 years","volume":"11","author":"Taylor","year":"2011","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.domaniend.2018.04.003_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1939-165X.2010.00227.x","article-title":"The effects of body weight, body condition score, sex, and age on serum fructosamine concentrations in clinically healthy cats","volume":"39","author":"Gilor","year":"2010","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib41","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomized, double-blinded, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.domaniend.2018.04.003_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1939-165X.2009.00133.x","article-title":"Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses","volume":"38","author":"Radin","year":"2009","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.domaniend.2015.10.001","article-title":"Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats","volume":"54","author":"McMillan","year":"2016","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2018.04.003_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1439-0396.2001.00322.x","article-title":"Leptin, body fat content and energy expenditure in intact and gonadectomized adult cats: a preliminary study","volume":"85","author":"Martin","year":"2001","journal-title":"J Anim Physiol Anim Nutr"},{"key":"10.1016\/j.domaniend.2018.04.003_bib45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.domaniend.2018.04.003_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12917-017-1011-x","article-title":"Differential circulating concentrations of adipokines, glucagon and adropin in a clinical population of lean, overweight and diabetic cats","volume":"13","author":"Zapata","year":"2017","journal-title":"BMC Vet Res"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724018300237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724018300237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T18:24:07Z","timestamp":1561659847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0739724018300237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"alternative-id":["S0739724018300237"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2018.04.003","relation":{},"ISSN":["0739-7240"],"issn-type":[{"value":"0739-7240","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}